Search Reports
Categories
Categories

Global Anti Neprilysin Market

Global Anti Neprilysin Market Research Report 2025(Status and Outlook)

Report Code : PHA3298
Published Date : 17 July, 1905 | No of Pages: 129

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Anti-neprilysin refers to a class of drugs that inhibit the enzyme neprilysin, which is involved in breaking down beneficial peptides such as natriuretic peptides, leading to improved cardiovascular outcomes. These drugs, often combined with angiotensin receptor blockers (e.g., sacubitril/valsartan), are primarily used to treat heart failure with reduced ejection fraction (HFrEF) by enhancing vasodilation, reducing sodium retention, and mitigating adverse cardiac remodeling. The market for anti-neprilysin drugs is driven by the increasing prevalence of heart failure, aging populations, and growing awareness of advanced treatment options. Major players include Novartis (with its leading brand Entresto), while competition is intensifying as more pharmaceutical companies explore combination therapies and next-generation inhibitors. Regulatory approvals, clinical efficacy data, and reimbursement policies significantly influence market dynamics, with North America and Europe dominating due to high adoption rates, while emerging markets in Asia and Latin America show growth potential due to rising healthcare investments. Challenges include high treatment costs, stringent regulatory hurdles, and the need for long-term safety data, but innovation in drug formulations and expanded indications (e.g., heart failure with preserved ejection fraction) present future opportunities.

This report offers a comprehensive and in-depth analysis of the global Anti Neprilysin market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Anti Neprilysin market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Anti Neprilysin market.
Global Anti Neprilysin Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd

Market Segmentation (by Type)
Sacubitril
TD-0714
STR-324
PL-265
LHW-090

Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti Neprilysin Market
Overview of the regional outlook of the Anti Neprilysin Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti Neprilysin Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Anti Neprilysin, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Anti Neprilysin
      1.2 Key Market Segments
            1.2.1 Anti Neprilysin Segment by Type
            1.2.2 Anti Neprilysin Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Anti Neprilysin Market Overview
      2.1 Global Market Overview
            2.1.1 Global Anti Neprilysin Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Anti Neprilysin Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Anti Neprilysin Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Anti Neprilysin Product Life Cycle
      3.3 Global Anti Neprilysin Sales by Manufacturers (2020-2025)
      3.4 Global Anti Neprilysin Revenue Market Share by Manufacturers (2020-2025)
      3.5 Anti Neprilysin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Anti Neprilysin Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Anti Neprilysin Market Competitive Situation and Trends
            3.8.1 Anti Neprilysin Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Anti Neprilysin Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Anti Neprilysin Industry Chain Analysis
      4.1 Anti Neprilysin Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Anti Neprilysin Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Anti Neprilysin Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Anti Neprilysin Market
      5.7 ESG Ratings of Leading Companies
  6 Anti Neprilysin Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Anti Neprilysin Sales Market Share by Type (2020-2025)
      6.3 Global Anti Neprilysin Market Size Market Share by Type (2020-2025)
      6.4 Global Anti Neprilysin Price by Type (2020-2025)
  7 Anti Neprilysin Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Anti Neprilysin Market Sales by Application (2020-2025)
      7.3 Global Anti Neprilysin Market Size (M USD) by Application (2020-2025)
      7.4 Global Anti Neprilysin Sales Growth Rate by Application (2020-2025)
  8 Anti Neprilysin Market Sales by Region
      8.1 Global Anti Neprilysin Sales by Region
            8.1.1 Global Anti Neprilysin Sales by Region
            8.1.2 Global Anti Neprilysin Sales Market Share by Region
      8.2 Global Anti Neprilysin Market Size by Region
            8.2.1 Global Anti Neprilysin Market Size by Region
            8.2.2 Global Anti Neprilysin Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Anti Neprilysin Sales by Country
            8.3.2 North America Anti Neprilysin Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Anti Neprilysin Sales by Country
            8.4.2 Europe Anti Neprilysin Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Anti Neprilysin Sales by Region
            8.5.2 Asia Pacific Anti Neprilysin Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Anti Neprilysin Sales by Country
            8.6.2 South America Anti Neprilysin Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Anti Neprilysin Sales by Region
            8.7.2 Middle East and Africa Anti Neprilysin Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Anti Neprilysin Market Production by Region
      9.1 Global Production of Anti Neprilysin by Region(2020-2025)
      9.2 Global Anti Neprilysin Revenue Market Share by Region (2020-2025)
      9.3 Global Anti Neprilysin Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Anti Neprilysin Production
            9.4.1 North America Anti Neprilysin Production Growth Rate (2020-2025)
            9.4.2 North America Anti Neprilysin Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Anti Neprilysin Production
            9.5.1 Europe Anti Neprilysin Production Growth Rate (2020-2025)
            9.5.2 Europe Anti Neprilysin Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Anti Neprilysin Production (2020-2025)
            9.6.1 Japan Anti Neprilysin Production Growth Rate (2020-2025)
            9.6.2 Japan Anti Neprilysin Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Anti Neprilysin Production (2020-2025)
            9.7.1 China Anti Neprilysin Production Growth Rate (2020-2025)
            9.7.2 China Anti Neprilysin Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Bioprojet SCR
            10.1.1 Bioprojet SCR Basic Information
            10.1.2 Bioprojet SCR Anti Neprilysin Product Overview
            10.1.3 Bioprojet SCR Anti Neprilysin Product Market Performance
            10.1.4 Bioprojet SCR Business Overview
            10.1.5 Bioprojet SCR SWOT Analysis
            10.1.6 Bioprojet SCR Recent Developments
      10.2 Novartis International AG
            10.2.1 Novartis International AG Basic Information
            10.2.2 Novartis International AG Anti Neprilysin Product Overview
            10.2.3 Novartis International AG Anti Neprilysin Product Market Performance
            10.2.4 Novartis International AG Business Overview
            10.2.5 Novartis International AG SWOT Analysis
            10.2.6 Novartis International AG Recent Developments
      10.3 Pharmaleads SA
            10.3.1 Pharmaleads SA Basic Information
            10.3.2 Pharmaleads SA Anti Neprilysin Product Overview
            10.3.3 Pharmaleads SA Anti Neprilysin Product Market Performance
            10.3.4 Pharmaleads SA Business Overview
            10.3.5 Pharmaleads SA SWOT Analysis
            10.3.6 Pharmaleads SA Recent Developments
      10.4 Theravance Biopharma Inc.
            10.4.1 Theravance Biopharma Inc. Basic Information
            10.4.2 Theravance Biopharma Inc. Anti Neprilysin Product Overview
            10.4.3 Theravance Biopharma Inc. Anti Neprilysin Product Market Performance
            10.4.4 Theravance Biopharma Inc. Business Overview
            10.4.5 Theravance Biopharma Inc. Recent Developments
      10.5 Cipla Limited
            10.5.1 Cipla Limited Basic Information
            10.5.2 Cipla Limited Anti Neprilysin Product Overview
            10.5.3 Cipla Limited Anti Neprilysin Product Market Performance
            10.5.4 Cipla Limited Business Overview
            10.5.5 Cipla Limited Recent Developments
      10.6 Oceanic Pharmachem Pvt. Ltd
            10.6.1 Oceanic Pharmachem Pvt. Ltd Basic Information
            10.6.2 Oceanic Pharmachem Pvt. Ltd Anti Neprilysin Product Overview
            10.6.3 Oceanic Pharmachem Pvt. Ltd Anti Neprilysin Product Market Performance
            10.6.4 Oceanic Pharmachem Pvt. Ltd Business Overview
            10.6.5 Oceanic Pharmachem Pvt. Ltd Recent Developments
  11 Anti Neprilysin Market Forecast by Region
      11.1 Global Anti Neprilysin Market Size Forecast
      11.2 Global Anti Neprilysin Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Anti Neprilysin Market Size Forecast by Country
            11.2.3 Asia Pacific Anti Neprilysin Market Size Forecast by Region
            11.2.4 South America Anti Neprilysin Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Anti Neprilysin by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Anti Neprilysin Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Anti Neprilysin by Type (2026-2033)
            12.1.2 Global Anti Neprilysin Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Anti Neprilysin by Type (2026-2033)
      12.2 Global Anti Neprilysin Market Forecast by Application (2026-2033)
            12.2.1 Global Anti Neprilysin Sales (K MT) Forecast by Application
            12.2.2 Global Anti Neprilysin Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400